Idera Pharmaceuticals Inc. (IDRA)

2.55
0.04 1.50
NASDAQ : Health Technology
Prev Close 2.59
Open 2.59
Day Low/High 2.53 / 2.61
52 Wk Low/High 2.25 / 10.95
Volume 27.86K
Avg Volume 359.80K
Exchange NASDAQ
Shares Outstanding 28.02M
Market Cap 73.14M
EPS -2.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Idera Pharmaceuticals (IDRA) Is Today's Strong On High Volume Stock

Idera Pharmaceuticals (IDRA) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a strong on high relative volume candidate

6 Stocks Under $10 Triggering Breakout Trades

6 Stocks Under $10 Triggering Breakout Trades

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Idera Pharmaceuticals (IDRA) Flagged As Strong On High Volume

Idera Pharmaceuticals (IDRA) Flagged As Strong On High Volume

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a strong on high relative volume candidate

First Week of September 18th Options Trading For Idera Pharmaceuticals (IDRA)

First Week of September 18th Options Trading For Idera Pharmaceuticals (IDRA)

Investors in Idera Pharmaceuticals Inc saw new options become available this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IDRA options chain for the new September 18th contracts and identified one put and one call contract of particular interest.

Was This a Good Test of the Market Low?

It's tough to get a handle on sentiment.

Short Interest In Idera Pharmaceuticals Increases 16%

Short Interest In Idera Pharmaceuticals Increases 16%

The most recent short interest data has been released by the NASDAQ for the 06/15/2015 settlement date, which shows a 3,146,585 share increase in total short interest for Idera Pharmaceuticals Inc , to 22,724,995, an increase of 16.07% since 05/29/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week Of February 2016 Options Trading For Idera Pharmaceuticals (IDRA)

First Week Of February 2016 Options Trading For Idera Pharmaceuticals (IDRA)

Investors in Idera Pharmaceuticals Inc saw new options become available this week, for the February 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

4 Breakout Biotech Stocks Under $10 to Watch

4 Breakout Biotech Stocks Under $10 to Watch

These biotech stocks that trade for under $10 a share could be setting up to break out and trade higher soon.

Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage

Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage

Idera Phamaceuticals (IDRA) stock is higher this morning after the company had coverage initiated at JPMorgan Chase with an 'overweight' rating.

Analysts' Actions -- EMC, Lowe's, Micron and More

Analysts' Actions -- EMC, Lowe's, Micron and More

Here are Monday's top research calls, including a downgrade of EMC and upgrade of Lowe's.

I Still Don't Hear a Whoosh

Somebody needs to huff and puff and blow this market down.

3 Stocks Under $10 Triggering Breakout Trades

3 Stocks Under $10 Triggering Breakout Trades

These under-$10 are making big moves higher today. Keep them on your breakout trading radar.

Idera Pharmaceuticals (IDRA) Weak On High Volume Today

Idera Pharmaceuticals (IDRA) Weak On High Volume Today

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a weak on high relative volume candidate

What Is the TRIN Telling Us?

Trading Index has been running at a high level.

First Week of July 17th Options Trading For Idera Pharmaceuticals (IDRA)

First Week of July 17th Options Trading For Idera Pharmaceuticals (IDRA)

Investors in Idera Pharmaceuticals Inc saw new options begin trading this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IDRA options chain for the new July 17th contracts and identified one put and one call contract of particular interest.

Strong On High Volume: Idera Pharmaceuticals (IDRA)

Strong On High Volume: Idera Pharmaceuticals (IDRA)

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a strong on high relative volume candidate

Market's Upside Recipe Is Missing Something

Action is slow, but it was a bad day for bonds.

Idera Pharmaceuticals (IDRA) Is Strong On High Volume Today

Idera Pharmaceuticals (IDRA) Is Strong On High Volume Today

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a strong on high relative volume candidate

First Week of IDRA June 19th Options Trading

First Week of IDRA June 19th Options Trading

Investors in Idera Pharmaceuticals Inc saw new options become available this week, for the June 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IDRA options chain for the new June 19th contracts and identified the following put contract of particular interest.

Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock

Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a weak on high relative volume candidate

Interesting IDRA Put And Call Options For November 20th

Interesting IDRA Put And Call Options For November 20th

Investors in Idera Pharmaceuticals Inc saw new options begin trading this week, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D (Sell)